Biomedion GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Biomedion GmbH - overview
Established
2000
Location
Berlin, -, Germany
Primary Industry
Software
About
Based in Berlin, Germany, and founded in 2000, Biomedion GmbH is a global Compliance Management Software company providing controlled content and raw data management solutions for the life science industry. In February 2022, Main Capital Partners invested in Biomedion GmbH. As of 2022, Dirk Aulike is the CEO and Andreas Suchanek is the president of the company. The company's products include neuronOS Platform, iPQM, iTMF, iRCS, iRAW, and iARQ.
Biomedion’s flagship application is the holistic data management platform neuronOS, which allows life and health science companies to collect raw data in a Good Laboratory Practice (GLP)-compliant manner and to store it in a F. A. I. R.
manner (findable, accessible, interoperable, and reusable). The firm allows its customers to be continuously audit-ready in real-time in compliance with GxP requirements, enabling clients in the life and health sciences industry to address its growing number of regulations and providing professional and validation services. The enterprise serves industries including biotech, pharma, CRO, CMO, GLP laboratory, and diagnostic microscopy. The organization plans to use the February 2022 investment to strengthen its long-term relationship with its customers and partners and to implement a strategy of growth both organically and through acquisitions, and also plans to extend its reach across Europe and North America.
Current Investors
Main Capital Partners
Primary Industry
Software
Sub Industries
Pharmaceutical Research & Development, Medical Software
Website
www.biomedion.com
Verticals
Cloud Computing, HealthTech
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Biomedion GmbH - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - |
| EBITDA (USD) | - | - | - | - | - | - | - | - | - |
| Operating Income (USD) | - | - | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - | - | - | - |
| NET Income (USD) | (16,197.2) | (574,664.6) | 2,275.4 | 229,586.7 | 27,259.3 | (188,559.3) | - | - | - |
| % Net Margin | - | - | - | - | - | - | - | - | - |
Biomedion GmbH - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | iTernity GmbH | - | ||||||||
| Buyout | Completed | Biomedion GmbH | - |
Displaying 1 - 2 of 2
Biomedion GmbH - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.